HDM1002 tablets for weight loss in Chinese adults
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests an experimental tablet called HDM1002 for weight loss in Chinese adults who are overweight or obese. It aims to see if the medication is safe and helps with weight management.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- Your BMI (body mass index) is between 24 and 36.
- You agree to use effective birth control if you could become pregnant or get someone pregnant.
- You have not gained or lost more than 5% of your body weight in the past 3 months.
- You do not have a history of diabetes or serious health problems like heart disease or pancreatitis.
- You have not used weight-loss drugs in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, HDM1005, to help people with obesity or overweight who do not have diabetes lose weight. It is for Chinese adults who have a high body mass index (BMI) or a BMI above 24 with weight-related health problems like high blood pressure or fatty liver.
This study tests how a new drug called HDM1002 leaves the body, using a tiny amount of a radioactive marker. It's for healthy men, and the results will help researchers understand how the drug works.
This study looks at how the drug HDM1002 is absorbed by the body, both when taken with food and on an empty stomach. It helps researchers understand the best way to take the medication.
This trial tests a medicine called HDM1002 in people who have different levels of liver function. It aims to see how the liver affects the drug and if it is safe.
This study tests whether a new injectable medication called HDM1005 works as well as tirzepatide (a GLP-1 drug) for weight loss in adults with obesity but no diabetes. Both medications work similarly in the body to help control appetite and weight.
This trial tests a new medication, HDM1002, to help people with excess weight lose weight and keep it off. You may qualify if you have a high BMI or a lower BMI with weight-related health problems, and you have struggled to lose weight through diet and exercise alone.
Hear when a new Glucagon-Like Peptide-1 Receptor Agonists trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.